DOXORUBICIN Accord liposomal 20 mg/10 ml conc perf
7680689610016
Pharmacode 1133329
CH-68961
L01DB01
07.16.1.
Active substances:
1 / 3
google
Details
- GTIN
- 7680689610016
- Pharmacode
- 1133329
- Product number
- 6896101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- doxorubicini hydrochloridum 20 mg, phosphatidylcholinum ex soja hydrogenatum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, cholesterolum, histidinum, saccharum, acidum hydrochloridum concentratum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile, q.s. ad suspensionem pro 10 ml corresp. natrium max. 0.319 mg.
Articles (1)
Doxorubicin Accord liposomal 20 mg/10 ml, Konzentrat zur Herstellung einer Infusionsdispersion
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
doxorubicini hydrochloridum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
phosphatidylcholinum ex soja hydrogenatum
|
- | Substance | HNIDK |
|
N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum
|
- | Substance | HNIDK |
|
cholesterolum
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
acidum hydrochloridum concentratum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 180.45
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68961
- Drug name
- Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
- Galenic form
- KOIND
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 09/01/2025
- Authorization expiration date
- 08/01/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DOXORUBICIN Accord liposomal 20 mg/10 ml conc perf
- Description (DE)
- DOXORUBICIN Accord liposomal 20 mg/10 ml Konz Inf
- Market launch
- 09/01/2025
- Narcotic (BTM)
- No